Replies to post #56532 on iQSTEL Inc (IQST)

[snow]

"However, its two closest comparables, Cogent and IDT, trade at a multiple of
10.5x EBITDA, which would suggest a $22 price target for IQST shares. One admitted flaw in our methodology is that
it includes the full consolidated EBITDA for each operating subsidiary, while most are not wholly owned. Based on the
implied $11.3 million to bring its stakes up to 100% (based on the original purchase prices), this would bring our price
target down to $14 or $18 based on the two close comps."

[snow]

"Earnings Per Share Normalized to exclude unusual items
Ticker Symbol IQST FYE - December 2024 2025E 2026E 2026E
Market NASDAQ 1Q - March ($0.37) ($0.44) A ($0.09) $0.01
Stock Price $9.88 2Q - June ($0.90) ($0.49) ($0.08) $0.02
52 wk High $32.68 3Q - September ($0.40) ($0.45) ($0.07) $0.01
52 wk Low $5.22 4Q - December ($0.57) $0.05 $0.02 $0.02
Year ($2.63) ($1.30) ($0.21) $0.06)

The above is what the analyst expects: a loss per share of 21 cents during 2026. I guess the earnings of 6 cents per share refers to 2027, since 2026 is mentioned twice. The comperable comapny IDT traded at a p/e ratio of about 15 based on trailing earnings. If IQST were to achieve earnings per share of 6 cents and traded at the same p/e ratio of 15 the price per share would be 90 cents in 2027.